David Feifel

8.7k total citations · 2 hit papers
133 papers, 5.3k citations indexed

About

David Feifel is a scholar working on Social Psychology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Feifel has authored 133 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Social Psychology, 38 papers in Psychiatry and Mental health and 32 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Feifel's work include Neuroendocrine regulation and behavior (41 papers), Receptor Mechanisms and Signaling (26 papers) and Schizophrenia research and treatment (22 papers). David Feifel is often cited by papers focused on Neuroendocrine regulation and behavior (41 papers), Receptor Mechanisms and Signaling (26 papers) and Schizophrenia research and treatment (22 papers). David Feifel collaborates with scholars based in United States, Canada and Sweden. David Feifel's co-authors include Kai MacDonald, Paul D. Shilling, Arpi Minassian, Jacob S. Ballon, Gilia Melendez, Franco J. Vaccarino, Michael P. Wilson, Neal R. Swerdlow, Tammi L. Reza and William Perry and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

David Feifel

132 papers receiving 5.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial

2019 264 citations David Feifel et al. profile →
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

2023 96 citations Guy M. Goodwin, David Feifel et al. Neuropsychopharmacology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David Feifel	1.8k	1.3k	1.3k	1.3k	895	133	5.3k
Jeremy D. Coplan	1.4k 0.8×	1.2k 0.9×	1.1k 0.8×	2.3k 1.8×	386 0.4×	144	7.8k
Arpi Minassian	697 0.4×	1.2k 0.9×	896 0.7×	591 0.5×	243 0.3×	96	3.6k
Naresh P. Emmanuel	1.0k 0.6×	1.4k 1.1×	1.6k 1.2×	2.1k 1.6×	148 0.2×	106	6.7k
B. Gallhofer	1.3k 0.7×	1.2k 0.9×	414 0.3×	890 0.7×	229 0.3×	99	3.7k
Margaret Haney	694 0.4×	927 0.7×	4.3k 3.2×	1.2k 0.9×	513 0.6×	176	8.5k
Audrey R. Tyrka	1.1k 0.6×	940 0.7×	543 0.4×	3.4k 2.6×	304 0.3×	140	9.0k
Zeev Kaplan	1.1k 0.6×	1.5k 1.1×	820 0.6×	1.7k 1.3×	296 0.3×	125	6.3k
Ebrahim Haroon	1.0k 0.6×	1.2k 0.9×	399 0.3×	471 0.4×	277 0.3×	77	7.3k
Stuart Checkley	818 0.5×	980 0.7×	803 0.6×	856 0.7×	509 0.6×	105	4.8k
David C. Jimerson	456 0.3×	1.0k 0.8×	982 0.7×	2.1k 1.6×	859 1.0×	89	5.0k

Countries citing papers authored by David Feifel

Since Specialization

Citations

This map shows the geographic impact of David Feifel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Feifel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Feifel more than expected).

Fields of papers citing papers by David Feifel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Feifel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Feifel. The network helps show where David Feifel may publish in the future.

Co-authorship network of co-authors of David Feifel

This figure shows the co-authorship network connecting the top 25 collaborators of David Feifel. A scholar is included among the top collaborators of David Feifel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Feifel. David Feifel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Goodwin, Guy M., Anna Nowakowska, Boadie W. Dunlop, et al.. (2025). Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder. The Journal of Clinical Psychiatry. 86(1). 3 indexed citations

2.

Liu, Peiwei, Tian Lin, Håkan Fischer, David Feifel, & Natalie C. Ebner. (2024). Effects of four-week intranasal oxytocin administration on large-scale brain networks in older adults. Neuropharmacology. 260. 110130–110130.

3.

Lin, Tian, et al.. (2024). Effects of chronic intranasal oxytocin on visual attention to faces vs. natural scenes in older adults. Psychoneuroendocrinology. 164. 107018–107018. 3 indexed citations

4.

Goodwin, Guy M., David Feifel, John R. Kelly, et al.. (2023). Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. Neuropsychopharmacology. 48(10). 1492–1499. 96 indexed citations breakdown →

5.

Young, Jared W., et al.. (2019). Oxytocin improves probabilistic reversal learning but not effortful motivation in Brown Norway rats. Neuropharmacology. 150. 15–26. 19 indexed citations

6.

Feifel, David, et al.. (2016). Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil. Journal of Visualized Experiments. 2 indexed citations

7.

Feifel, David, et al.. (2016). Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil. Journal of Visualized Experiments. 1 indexed citations

8.

Singh, Fiza, et al.. (2015). Effects of intranasal oxytocin on neural processing within a socially relevant neural circuit. European Neuropsychopharmacology. 26(3). 626–630. 17 indexed citations

9.

MacDonald, Kai & David Feifel. (2014). Oxytocin׳s role in anxiety: A critical appraisal. Brain Research. 1580. 22–56. 117 indexed citations

10.

Keiser, Ashley A., et al.. (2014). Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male Brown Norway rats.. Experimental and Clinical Psychopharmacology. 22(6). 541–547. 17 indexed citations

11.

Feifel, David, et al.. (2012). Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia. Schizophrenia Research. 139(1-3). 207–210. 97 indexed citations

12.

Wilson, Michael P., Kai MacDonald, Gary M. Vilke, & David Feifel. (2011). A Comparison of the Safety of Olanzapine and Haloperidol in Combination with Benzodiazepines in Emergency Department Patients with Acute Agitation. Journal of Emergency Medicine. 43(5). 790–797. 28 indexed citations

13.

Cutler, Andrew J., Stuart Montgomery, David Feifel, et al.. (2009). Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder. The Journal of Clinical Psychiatry. 70(4). 526–539. 114 indexed citations

14.

Feifel, David, et al.. (2009). The Brattleboro Rat Displays a Natural Deficit in Social Discrimination That Is Restored by Clozapine and A Neurotensin Analog. Neuropsychopharmacology. 34(8). 2011–2018. 54 indexed citations

15.

Shilling, Paul D. & David Feifel. (2002). SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI. Psychopharmacology. 164(3). 285–293. 8 indexed citations

16.

Feifel, David, Tammi L. Reza, David J. Wustrow, & M. Duff Davis. (1999). Novel Antipsychotic-Like Effects on Prepulse Inhibition of Startle Produced by a Neurotensin Agonist. Journal of Pharmacology and Experimental Therapeutics. 288(2). 710–713. 73 indexed citations

17.

Feifel, David, et al.. (1999). The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating. Psychopharmacology. 146(2). 175–179. 29 indexed citations

18.

Feifel, David. (1999). Individual differences in prepulse inhibition of startle as a measure of individual dopamine function.. Behavioral Neuroscience. 113(5). 1020–1029. 30 indexed citations

19.

Feifel, David. (1999). Antipsychotic Potential of CCK-Based Treatments: An Assessment Using the Prepulse Inhibition Model of Psychosis. Neuropsychopharmacology. 20(2). 141–149. 30 indexed citations

20.

Feifel, David, et al.. (1993). Evidence for a Common Neural Mechanism Mediating Growth Hormone-Releasing Factor-Induced and Somatostatin-lnduced Feeding. Neuroendocrinology. 57(2). 299–305. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact